Join to View Full Profile
7979 N Shadeland AveSte 200Castleton, IN 46250
Phone+1 317-621-4300
Fax+1 317-621-4301
Dr. Walling is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2001 - 2004
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1998 - 2000
Medical College of WisconsinClass of 1997
Certifications & Licensure
IN State Medical License 2004 - 2025
GA State Medical License 2001 - 2013
OH State Medical License 2000 - 2003
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Publications & Presentations
PubMed
- 17 citationsBRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breas...Bryan P Schneider, Guanglong Jiang, Tarah J Ballinger, Fei Shen, Christopher Chitambar
Journal of Clinical Oncology. 2022-02-01 - 89 citationsA phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non–small cell lung cancer: Hoosier cancer ...Greg Andrew Durm, Salma K. Jabbour, Sandra Althouse, Ziyue Liu, Ahad Ali Sadiq
Cancer. 2020-10-01 - 180 citationsAssociation of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer:...Milan Radovich, Guanglong Jiang, Bradley A. Hancock, Christopher R. Chitambar, Rita Nanda
JAMA Oncology. 2020-09-01
Journal Articles
- Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy with Disease Recurrence in Patients with Triple-Negative Breast CancerRita Nanda, Carla Falkson, Filipa C Lynce, Claudine Isaacs, Marcelo Blaya, Elisavet Paplomata, Radhika Walling, Reshma Mahtani, Tarah J Ballinger, Kathy D Miller, Brya..., JAMA Oncology
Authored Content
- Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy with Disease Recurrence in Patients with Triple-Negative Breast CancerJuly 2020
Press Mentions
Community MD Anderson Expands Access to Cancer Care with New Location in CarmelApril 14th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
